Cited in:


This article has been cited by:

  1. 1
    Hiroyuki Takahashi, Jonathan I. Epstein, Shin Wakui, Toshihiro Yamamoto, Bungo Furusato, Miao Zhang, Differences in prostate cancer grade, stage, and location in radical prostatectomy specimens from United States and Japan, The Prostate, 2014, 74, 3
  2. 2
    Aleksandra Strzępek, Karolina Kaczmarczyk, Magdalena Białas, Joanna Szpor, Grzegorz Dyduch, Tomasz Szopiński, Piotr Chłosta, Krzysztof Okoń, ERG positive prostatic cancer may show a more angiogenetic phenotype, Pathology - Research and Practice, 2014, 210, 12, 897


  3. 3
    Chunni Wang, Lin Wang, Bo Su, Ning Lu, Jingjing Song, Xiaoqing Yang, Weiwei Fu, Weiwei Tan, Bo Han, Serine protease inhibitor Kazal type 1 promotes epithelial–mesenchymal transition through EGFR signaling pathway in prostate cancer, The Prostate, 2014, 74, 7